ENPP2 and cardiovascular disorder: Despite indications that LPA signaling is upregulated in the obese heart [16], it remains to be tested if and to what extent the ATX–LPA axis impacts cardiovascular disease associated with obesity, insulin resistance, and diabetes, and whether LPA signaling influences cardiomyopathy and heart failure under these conditions.